Studying human brain tissue in 3D Date 14 March 2018 An international team has developed a cutting-edge technique, enabling human brain tissue to be studied in 3D.
Calcium may play a role in Parkinson's Date 19 February 2018 New international research suggests that too much calcium inside brain cells may trigger a chain reaction that leads to Parkinson's.
Investing in a new treatment for dyskinesia Date 24 January 2018 We're partnering with US company Neurolixis to accelerate the development of a drug that could prevent dyskinesia, a debilitating side effect of Parkinson's medication.
Research into flu and the onset of Parkinson's Date 16 January 2018 A study, featured in the Daily Mail, suggests a link between certain types of flu and risk of Parkinson's.
More than 12,000 Scots living with Parkinson's and numbers continue to rise Date 8 January 2018 New figures from Parkinson's UK show that more than 12,000 Scots are now living with Parkinson's, and numbers are continuing to rise.
Parkinson's diagnoses set to increase by a fifth by 2025 Date 8 January 2018 The number of people diagnosed and living with Parkinson’s is increasing, according to our latest research.
Research on caffeine to diagnose Parkinson's Date 4 January 2018 Researchers in Japan have discovered that people with Parkinson's may have lower levels of caffeine in their blood after drinking tea and coffee.
Tapeworm drug shows promise for Parkinson's Date 12 December 2017 Research supported by Parkinson's UK has identified a medicine used to treat tapeworm infections which could lead to new treatments for people with Parkinson's.
Further evidence on the benefits of pimavanserin Date 25 September 2017 UK researchers publish further evidence highlighting the need to licence pimavanserin for hallucinations and delusions in Parkinson's.
Asthma drugs could decrease risk of Parkinson's Date 4 September 2017 New research suggests that a type of asthma drug that activates a protein called beta-adrenoceptors, may decrease risk of Parkinson's.
